JEFFREY BOSLEY: Open Payments
NPI 1922073196 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 87 payments from 25 companies in 2025. Trend: 2023 $1,045 · 2024 $2,389 · 2025 $2,156
Food & beverage: $2,091Education: $65
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $424 |
| Janssen Biotech, Inc. | 7 | $233 |
| Organon LLC | 10 | $183 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| LEO Pharma Inc. | 4 | $161 |
| UCB, Inc. | 7 | $136 |
| ABBVIE INC. | 5 | $100 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $94 |
| Galderma Laboratories, L.P. | 4 | $86 |
| Arcutis Biotherapeutics, Inc. | 3 | $68 |
Products named: DUPIXENT, TREMFYA, ANZUPGO, Bimzelx, VTAMA, SKYRIZI, NEMLUVIO, Zoryve.
Industry payments across AZ — which companies pay providers there.
